Active and Passive Immunization.pptx

4,878 views 49 slides Oct 09, 2022
Slide 1
Slide 1 of 49
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49

About This Presentation

Types of immunity


Slide Content

ACTIVE AND PASSIVE IMMUN IZATION

The Nature of Disease Pathogenic Organisms Genetic Disorders Toxic Chemicals Other Environmental Factors Physical Damage to Organs Nutritional Disorders

Types of Pathogenic Organisms Viruses Bacteria Protozoan Fungi Animal Parasites

Mechanisms of Disease by Pathogens Utilization of host nutritional resources Physical damage to host tissues Production of toxic substances Chromosomal and gene damage Body cells behave abnormally

Defense Mechanisms External Defense Internal Defense Immune Defense

Skin acts as barrier to microbes and viruses sweat has a low pH Mucus traps foreign particles Tears Lysozyme has antimicrobial action Gastric stomach acid 1 st Line of Defense

Body Coverings: The Skin sweat gland epidermis seb a ce o us glands

Body Coverings: Mucous Membranes mucus cilia

Phagocytic cells (WBCs) - Natural Killer (NK) Cells: attack virus infected cells • • Inflammatory Response Antimicrobial proteins Lysozyme Interferon An t i b o d i e s 2 nd Line of Defense

Nonspecific Phagocytosis Neut r ophils Monocytes Eosinophils

Mechanism of Phagocytosis Macrophage

Inflammatory Response Histamine & p r ost a g l and i ns released Capillaries dilate Clotting begins Chemotactic factors attract phagocytic cells Phagocytes consume pathogens & cell debris

Lymphatic System 3 rd Line of Defense Human

Immunity: The state of being immune from or insusceptible to a particular disease. T h e condi t ion that permits e ither natural or acqui r ed resistance to disease . The ability of the cell to react immunologically in the presence of antigen.

How immunity develops During the body’s first encounter with a pathogen there will be few lymphocytes with specific receptors It takes time to divide to form clones, B lymphocytes to secrete antibodies, T lymphocyte production If the same pathogen invades again persisting memory cells can give a faster, more effective response

Characteristics of Immunity Recognition of self versus non-self Response is specific Retains a “memory” allowing an accelerated second response Can respond to many different materials Involves lymphocytes and antibodies

Types of Immunity Active Immunity Naturally-Acquired Active Immunity Artificially-Acquired Active Immunity Passive Immunity Naturally-Acquired Passive Immunity Artificially-Acquired Passive Immunity

Types of Imm unit y

An infection is an example of acquiring natural immunity. It is called ACTIVE as your body needs to work to produce the necessary antibodies When a mother breast feeds her baby she passes antibodies to it. This is a way of acquiring PASSIVE immunity as it is a way of gaining antibodies without the immune system having to produce them. The thick, yellowish milk (colostrum) that is produced for the first few days after birth is particularly rich in antibodies. Natural immunity: active and passive

Artificial immunity: active and passive An alternative to natural immunity developing is to give vaccinations (artificial immunity) Antigen is injected into the body. This may be in the form of an inactivated bacterial toxin or attenuated (not harmful) virus which would promote ACTIVE immunity; or the injection of antibodies or antitoxins which would promote PASSIVE immunity (eg Clostridium tetani )

The production of antibodies against a specific disease by the immune system. Naturally acquired through disease Artificially acquired through vaccination Vaccines include inactivated toxins, killed microbes, parts of microbes, and viable but weakened microbes. Memory cells are only produced in active immunity. Protection for active immunity is permanent whereas in passive immunity it is only temporary. Antigens are only encountered in active immunity. Active immunity takes several weeks to become active but passive is immediate Active Immunity

A vaccinated person has a secondary response based on memory cells when encountering the specific pathogen. Routine immunization against infectious diseases such as measles and whooping cough, and has led to the eradication of smallpox, a viral disease. Unfortunately, not all infectious agents are easily managed by vaccination. HIV vaccine in the works

Passive Immunity When antibodies produced in one body (human or animal) are transfer to another to induce protection against disease. Body does not produce its own antibodies, depends upon ready-made antibodies. Passive immunity may be induced by: Administration of an antibody-containing preparation (immune globulin or antiserum) Transfer of maternal antibodies across the placenta Transfer of lymphocytes, to induce passive cellular immunity

Passive Immunity- Protection against disease through antibodies produced by another human being or animal . Ex. Maternal antibodies , Colostrum Passive immunity doesn’t last as long as active immunity (only weeks or months): No lymphocytes are stimulated to clone themselves No memory cells have been made Effective, but temporary as this type of immunity can only last as long as the antibodies/toxins last in the blood Passive Immunity Cntd…

Passive Immunity Cntd… Passive immunity can be transferred artificially by injecting antibodies from an animal that is already immune to a disease into another animal. Rabies treatment: injection with antibodies against rabies virus that are both passive immunizations (the immediate fight) and active immunizations (longer term defense).

Passive Immunity Cntd… Passive immunity differs from active immunity in the following respects : Immunity is rapidly established Immunity produced is only temporary (days to month) No education of the reticuloendothelial system A c ti v e imm u nit y i s s uperio r t o pa s si v e i m m unity because: Duration of protection is long lasting Severe reactions are rare Protective efficacy is more Active immunization is less expensive

V AC CINE S Types of vaccines

Vaccination Vaccination is a method of giving antigen to stimulate the immune response through active immunization. A vaccine is an immuno-biological substance designed to produce specific protection against a given disease. A vaccine is “antigenic” but not “pathogenic”. One of the most effective «weapons» in medicine 1798 Edward Jenner immunizes first time against smallpox 1885 Louis Pasteur prepares the 1st vaccine against Rabbies 1927 BCG (bacillus Galmette-Guerin) 1955 Salk vaccine against poliomyelitis 1960 MMR (Measles, Mumps and Rubella)……..

Types of vaccines Live vaccines Attenuated live vaccines Inactivated (killed vaccines) Toxoids Polysaccharide and polypeptide (cellular fraction) vaccines Surface antigen (recombinant) vaccines

Live vaccines Live vaccines are made from live infectious agents without any amendment. The only live vaccine is “Variola ” small pox vaccine , made of live vaccinia cow-pox virus (not variola virus) which is not pathogenic but antigenic, giving cross immunity for variola.

Live attenuated (avirulent) vaccines Virulent pathogenic organisms are treated to become attenuated and avirulent but antigenic. They have lost their capacity to induce full-blown disease but retain their immunogenicity. Attenuated – live microbe (usually virus) which has a vital function inactivated by heat, chemicals or genetic manipulation e.g. Rabies virus vaccine, MMR (Bacillus an t i b ody (Measles, Mumps and Rubella), BCG Calmette Guerin vaccine for M. tuberculosis Risk it could revert back to infectious agent will stimulate bo t h c e ll m ediated and mediated immune response

Live attenuated (avirulent) vaccines contd.. Live attenuated vaccines should not be administered to persons with suppressed immune response due to: Leukemia and lymphoma Other malignancies corticoste r o i ds an d a n t i -met a b o lic Re c eivi n g agents Radiation pregnancy

Inactivated (killed) vaccines Organisms are killed or inactivated by heat or chemicals but remain antigenic. They are usually safe but less effective than live attenuated vaccines. The only absolute contraindication to their administration is a severe local or general reaction to a previous dose

T oxoi d s They are prepared by detoxifying the exotoxins of some bacteria rendering them antigenic but not pathogenic. Adjuvant (e.g. alum precipitation) is used to increase the potency of vaccine. The antibodies produces in the body as a consequence of toxoid administration neutralize the toxic moiety produced during infection rather than act upon the organism itself. In general toxoids are highly efficacious and safe immunizing agents.

Polysaccharide and polypeptide vaccines They are prepared from extracted cellular fractions e.g. meningococcal vaccine from the polysaccharide antigen of the cell wall, the pneumococcal vaccine from the polysaccharide contained in the capsule of the organism, and hepatitis B polypeptide vaccine . Their efficacy and safety appear to be high.

Surface antigen (recombinant) vaccines It is p r epared b y clo n i n g HBsAg gene i n y east c e lls where it is expressed. HBsAg produced is then used for vaccine preparations. Their efficacy and safety also appear to be high.

TYPES OF VACCINES Live v a c cines Live A ttenuated vaccines Killed I n a c ti v at e d vaccines Toxoids Cellular fraction v acc in e s R e combi n an t vaccines Small pox variola vacc i ne BCG T y p h o i d oral Plague Typhoid Cholera Pertussis Plague Rabies Salk polio Intra- musc u l a r influenza Japanise e n ce p h a l i tis Diphtheria Tetanus Me n i n g o cocc a l polysaccharide vaccine P n e u moc o ccal polysaccharide vaccine Hepatitis B polypeptide vaccine Hepatitis B vaccine Oral polio Y e l l o w fever Measles Mumps Rubella Intranasal Influenza Typhus

Routes of administration Deep subcutaneous or intramuscular route (most vaccines) Oral route ( oral BCG vaccine) Intradermal route (BCG vaccine) Scarification (small pox vaccine) Intranasal route (live attenuated influenza vaccine)

Scheme of immunization Primary vaccination One dose vaccines (BCG, variola, measles, mumps, rubella, yellow fever) Multiple dose vaccines (polio, DPT (diphtheria, pertussis, tetanus toxoids), hepatitis B) Booster vaccination To maintain immunity level after it declines after some time has elapsed (DT , MMR ).

Periods of maintained immunity by vaccines Short period (months): Two years: Three to five years: Five or more years: Ten years: Solid immunity: cholera vaccine TAB vaccine DPT vaccine BCG vaccine Yellow fever vaccine MMR (measles, mumps, and rubella vaccines)

Levels of effectiveness Absolutely protective(100%): yellow fever vaccine Almost absolutely protective (99%): Variola, measles, mumps, rubella vaccines, and diphtheria and tetanus toxoids. Highly protective (80-95%): polio, BCG, Hepatitis B, and pertussis vaccines. Moderately protective (40-60%) TAB, cholera vaccine, and influenza killed vaccine.

The Cold Chain The "cold chain" is a system of storage and transport of vaccines at low temperature from the manufacturer to the actual vaccination site. The cold chain system is necessary because vaccine failure may occur due to failure to store and transport under strict temperature controls.

The Cold Chain Equipment Cold chain equipment consists of the following: Walk in cold rooms: They are located at regional level, meant to store vaccines up to 3 months and serve districts. Deep freezers (300 ltr) and Ice lined Refrigerators: supplied to all districts and the WIC locations to store vaccines. Deep freezers are used for making ice packs and to store OPV and measles vaccines. Small deep freezers and ILR (140 ltr) : One set is provided to PHCs, and Family Planning Centers

(d) Cold b o xe s : Cold b o x e s peri p heral c e n t er s . These are are s u p p l ied to all u s ed m a i n ly f o r transportation of the vaccines. (e) Vaccine carriers: Vaccine carriers are used to carry small quantities of vaccines (16-20 vials) for the out of reach sessions. 4 fully frozen ice packs are used for lining the sides, and vials of DPT, DT, TT and diluents should not be placed in direct contact with frozen ice packs. The carriers should be closed tightly. (f) Ice packs: The ice packs contain water and no salt should be added to it.

Among the vaccines, Polio vaccine is the most sensitive to heat, requiring storage at minus 20 degree C. Vaccines which must be stored in the FREEZER COMPARTMENT are : polio and measles. Vaccines which must be stored in the COLD PART but never allowed to freeze are : typhoid, DPT, tetanus toxoid, DT, BCG and diluents

Vaccination Coverage Vaccination coverage is the percent of at risk or susceptible individuals, or population who have been fully immunized against particular diseases by vaccines or toxoids. To be significantly effective in prevention of disease on mass or community level at least a satisfactory proportion (75% or more) of the at risk population must be immunized.

Herd immunity : At least 80-85% of the population need to be vaccinated to reduce the chance of somebody catching the disease – even some one who has not been vaccinated- to safe levels.

Ways of achieving satisfactory immunization coverage Efficient immunization service; urban and rural Health awareness and cooperation of the public Periodic mass immunization campaigns, to cover those who missed regular immunizations Outreach programs in rural and nomad areas, and home visits

Application of active immunization Infants and children expanded immunization program (schedule) Active immunization for adult females Vaccination for special occupations Vaccination for special life styles Vaccination for special environmental situations Vaccinations for special health status persons Vaccinations in travel Vaccines against bioterrorism
Tags